Whitehawk Therapeutics (WHWK) Return on Capital Employed Growth (5y) (2016 - 2026)

Whitehawk Therapeutics (WHWK) Return on Capital Employed Growth (5y) (2016 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 65,719.23 Bn 65,718.94 Bn -
2 Nanobiotix 1,933.82 Bn 1,933.76 Bn -
3 Akari Therapeutics 959.56 Bn 959.56 Bn -
4 BeOne Medicines 471.85 Bn 467.06 Bn 1.35 Bn
5 Vertex Pharmaceuticals 122.29 Bn 115.04 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.04 Bn 61.28 Bn 3.31 Bn
7 Belite Bio 62.06 Bn 62.06 Bn -
8 Argenx Se 55.78 Bn 50.60 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.47 Bn 34.47 Bn 959.66 Mn
10 Whitehawk Therapeutics 257.56 Mn 46.31 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -13,504.00
Dec 31, 2025 -33,409.00
Sep 30, 2025 -6,129.00
Jun 30, 2025 -3,959.00
Mar 31, 2025 1,092.00
Dec 31, 2024 -4,868.00
Sep 30, 2024 -1,991.00
Jun 30, 2024 -5,829.00
Mar 31, 2024 -5,071.00
Dec 31, 2023 -4,748.00
Sep 30, 2023 -4,279.00
Jun 30, 2023 7,457.00
Mar 31, 2023 12,793.00
Dec 31, 2022 7,056.00
Sep 30, 2022 2,870.00
Jun 30, 2022 -5,122.00
Mar 31, 2022 1,775.00
Dec 31, 2021 -19,692.00
Sep 30, 2021 -672,944.00
Jun 30, 2021 -421,995.00